(Q43792574)

26 November 2017

title

Mechanism-based inhibition of CYP1A2 by antofloxacin, an 8-NH2 derivative of levofloxacin in rats (English)

1 reference

26 November 2017

1 reference

Q Zhu

1

1 reference

26 November 2017

J Liao

2

1 reference

26 November 2017

L Xie

3

1 reference

26 November 2017

G J Wang

4

1 reference

26 November 2017

X D Liu

5

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 April 2009

1 reference

26 November 2017

1 reference

26 November 2017

volume

39

1 reference

26 November 2017

issue

4

1 reference

26 November 2017

page(s)

293-301

1 reference

Differences in caffeine and paraxanthine metabolism between human and murine CYP1A2.

26 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F00498250802709428

The effect of ciprofloxacin on theophylline pharmacokinetics in healthy subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802709428

Drug interactions in dentistry: the importance of knowing your CYPs

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802709428

Ciprofloxacin greatly increases concentrations and hypotensive effect of tizanidine by inhibiting its cytochrome P450 1A2-mediated presystemic metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802709428

Methadone, ciprofloxacin, and adverse drug reactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802709428

Mechanism-based inactivation of human liver microsomal CYP3A4 by rutaecarpine and limonin from Evodia fruit extract

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802709428

Effect of ciprofloxacin on the pharmacokinetics of ropivacaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802709428

Inhibitory effects of antiarrhythmic drugs on phenacetin O-deethylation catalysed by human CYP1A2.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802709428

Interaction study between enoxacin and fluvoxamine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802709428

Effect of levofloxacin on theophylline clearance during theophylline and clarithromycin combination therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802709428

Inhibition of caffeine metabolism by ciprofloxacin in children with cystic fibrosis as measured by the caffeine breath test

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802709428

Ciprofloxacin increases serum clozapine and N-desmethylclozapine: a study in patients with schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802709428

Potent Mechanism-Based Inhibition of Human CYP2B6 by Clopidogrel and Ticlopidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802709428

Drug-drug interactions with ciprofloxacin and other fluoroquinolones

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802709428

Accumulation of caffeine in healthy volunteers treated with furafylline

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802709428

The influence of quinolone derivatives on theophylline clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802709428

Pharmacokinetics of antofloxacin hydrochloride, a new fluoroquinolone antibiotic, after single oral dose administration in Chinese healthy male volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802709428

The influence of a newly developed quinolone: antofloxacin, on CYP activity in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802709428

Interaction of pefloxacin and enoxacin with the human cytochrome P450 enzyme CYP1A2

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F00498250802709428

10.1080/00498250802709428

21 January 2018

Identifiers

DOI

1 reference

26 November 2017

1 reference